Ph.D., economics, Massachusetts Institute of Technology; B.A., economics, Wellesley College
Summary of Experience:
Dr. Ling has extensive experience in pharmaceutical and management consulting, as well as health policy research. She has completed numerous scientific studies on pharmacoeconomics and health economics. She has been widely published in a range of academic journals, including those focused on public health, medicine, aging, and economics. Prior to joining Analysis Group, Dr. Ling worked at McKinsey & Company, helping major pharmaceutical companies and leading financial institutions identify opportunities and develop strategies for organizational improvement and growth. She also previously worked as an economist in the Health Economics and Outcomes Research division of Thomson Medstat, designing and conducting pharmacoeconomics studies using large administrative claims databases. She was a tenured Associate Professor of economics at California State University, Fullerton, and the Director of the university’s International Center for the Economics of Pharmaceuticals, Aging, and Health. Dr. Ling completed her post-doctoral training at Harvard Medical School.